Product
Zofran ODT
1 clinical trial
1 indication
Indication
HealthyClinical trial
Single-Dose Food In Vivo Bioequivalence Study of Ondansetron Orally Disintegrating Tablets (8 mg; Mylan) to Zofran ODT® Tablets (8 mg; GlaxoSmithKline) in Healthy VolunteersStatus: Completed, Estimated PCD: 2005-07-01